FdaApplication
BLA 125319
Identifiers
- fda_app_no: BLA125319
Properties
| Property | Value |
|---|---|
| applicant_name | Novartis Pharmaceuticals Corporation |
| application_type | BLA |
| approval_date | 2009-06-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ILARIS | CANAKINUMAB | 150MG | INJECTABLE;SUBCUTANEOUS |
| ILARIS | — | 150MG/ML | Injection |
2 products